Petauri Health

What Petauri Health does

Petauri Health, LLC is a Delaware-organized, private equity-backed healthcare commercialization platform serving life sciences companies (pharmaceutical, biotech, and medical device manufacturers) across the US and UK. The company is structured around six vertically integrated business units: Petauri Advance (medical and scientific communications across six agencies including BluePrint Oncology, Verascity Science, Cogency, FORCE Communications, DRIVE, MOMENTUM, and Propel), Petauri Kinect (health system engagement via the Networks of Excellence across 85+ IDNs and health systems covering 60+ million patients), Petauri Advisors (US market access research using the proprietary FIRST rapid-study tool and Shadow Formulary methodology), Petauri Evidence (global pricing, HTA navigation, and HEOR, operating internationally as Mtech Access Ltd), Petauri MAx (strategic payer market access marketing), and Artia Solutions (Medicaid access consulting using the proprietary Capsule tracking platform). The company supports 25 global pharmaceutical companies and partners with state Medicaid programs and other healthcare entities.

Revenue is generated through project-based consulting engagements, retainer agreements, and strategic advisory services across medical communications, market access, HEOR, evidence generation, and health system engagement. Pricing is quote-based and project-specific with no public pricing. Go-to-market is direct enterprise field sales supplemented by thought leadership content, webinars (Global Whispers, NHS Whispers), industry conferences (ISPOR, NHS ConfedExpo, Crossroads), and an in-house Petauri Evidence newsletter. The company is backed by Oak Hill Capital, whose representatives hold board seats, and the operational footprint spans nine offices including Nashville (headquarters), New York, Tallahassee, Carmel, and UK locations in Bicester, Nottingham, Cheadle, York, and London.

The underlying technology stack consists of three proprietary platforms — Capsule (Medicaid coverage tracking), FIRST (10-business-day payer insight delivery), and Connected Insights (real-world data dashboards) — embedded alongside Veeva-integrated content delivery and CRM/CLM capabilities. The platform is described as "AI-accelerated, expert-led," using approved enterprise AI for evidence synthesis and market access analytics with expert review and client-data safeguards, rather than as an AI-native offering.

Name

Petauri Health

Legal name

Petauri Health, LLC

Website

https://petauri.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Petauri Health is a PE-backed healthcare commercialization platform serving global pharmaceutical and biotech companies with integrated market access, HEOR, medical communications, and health system engagement services across the US and UK.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Professional Consulting Services: Petauri operates as a life sciences consulting firm providing integrated commercialization solutions. Revenue is generated through project-based consulting engagements, retainer agreements, and strategic advisory services across medical communications, market access, HEOR, and health system engagement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Petauri Health is a life sciences commercialization platform that provides integrated consulting services across medical communications, market access strategy, HEOR, health system engagement, and Medicaid access. The company operates through six business units (Petauri Advance, Petauri Kinect, Petauri Advisors, Petauri Evidence, Petauri MAx, and Artia Solutions) and supports pharmaceutical, biotech, medtech, and diagnostics companies across the product lifecycle from early development through post-launch in the US and UK markets.

Product overview

Petauri Health is a healthcare commercialization platform organized around six distinct business units that provide integrated, end-to-end services from early development through post-launch. The core portfolio includes: Petauri Advance (medical and scientific communications across six independent agencies covering oncology, rare disease, cardiometabolic, and emerging areas), Petauri Kinect (health system engagement focused exclusively on IDNs and health systems, with a Networks of Excellence covering 85+ systems and 60M patients), Petauri Advisors (commercialization insights and US market access research using proprietary tools like FIRST), Petauri Evidence (global pricing, HEOR, and HTA navigation spanning NICE, SMC, PBAC and other bodies), Petauri MAx (US payer market access marketing, value demonstration, and patient services), and Artia Solutions (Medicaid access consulting with a proprietary Capsule tracking platform). The platform is unified under Oak Hill Capital ownership and emphasizes integrated delivery across these units.

Differentiator

Problem solved

Functional benefit

Brands

• Petauri Advance: Medical and Scientific Communications agency network including BluePrint Oncology, Verascity Science, Cogency, FORCE Communications, DRIVE, MOMENTUM, and Propel
• Petauri Kinect
• Petauri Advisors
• Petauri Evidence
• Petauri MAx
• Artia Solutions
• Artia Solutions (Powered by Petauri)
• Capsule

Products and services

• Petauri Advance Medical and scientific communications unit offering strategic planning, scientific communications, expert engagement, and experiential medical education across six independent agencies (Blueprint Oncology, Verascity Science, Cogency, FORCE Communications, DRIVE, MOMENTUM, and Propel) covering oncology, rare disease, cardiometabolic, neuroscience, immunology, and emerging therapeutic areas.
• Petauri Kinect Health system engagement agency providing clinical market building, therapeutic adoption optimization, and a Networks of Excellence program spanning 85+ health systems and IDNs covering 60 million patients across brain health, MASH, oncology, chronic kidney disease, women's health, population health, and heart health.
• Petauri Advisors Market access consultancy providing primary and secondary market research, proprietary Frontline Insights Rapid Study Tool (FIRST), Shadow Formulary Research, and channel strategy development for life science organizations navigating the US healthcare landscape.
• Petauri Evidence Global pricing, market access, and HEOR business unit offering global pricing and market access strategy, local HTA navigation (NICE, SMC, AWMSG, NCPE, CDA-AMC, PBAC, EU JCA), health economics and statistics modeling, evidence synthesis, and value communications. Unites legacy Mtech Access and Delta Hat.
• Petauri MAx Strategic payer market access marketing unit providing payer insights generation, value demonstration, account manager resources, patient services and support, outcomes-focused training, and US pricing and market access strategy to optimize pathways to access and reimbursement.
• Artia Solutions Medicaid access consulting subsidiary offering drug launch strategy, financial modeling and bid analysis, product monitoring via the proprietary Capsule platform, account management, legislative and policy strategy, and hosting the biannual Crossroads conference. Founded in 2005; acquired by Petauri.
• Capsule Platform Proprietary, custom-built Medicaid tracking platform that surfaces updates on product and class status, new PDLs, P&T and DUR meeting information, market share data, and clinical and bid vendor activity for client and competitor drugs.
• Frontline Insights Rapid Study Tool (FIRST) Proprietary market access research application enabling actionable insights from payer and health system decision-makers in as fast as 10 business days, supporting agile response to market events.
• Connected Insights Real-world data dashboard platform offered as part of Petauri Evidence's digital tool offerings for payer engagement, market access, budget impact models, and CRM-integrated communication tools.
• Crossroads Conference Biannual conference convening Medicaid pharmacy administrators, Managed Care representatives, drug manufacturers, healthcare providers, pharmacists, advocacy groups, and public officials for Medicaid-focused dialogue and networking.
• Shadow Formulary Research Proprietary research methodology offered by Petauri Advisors within US pricing and market access services to inform competitive positioning and formulary strategy.

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• OPEN Health: Global life sciences services platform combining HEOR, market access, medical communications, and real-world evidence across pharma and biotech clients — directly comparable in service mix to Petauri Advance, Evidence, and MAx.
• Trinity Life Sciences: End-to-end life sciences commercialization partner covering evidence, access, medical communications, and insights; competes head-to-head with Petauri for pharma/biotech commercialization mandates.
• Beghou Consulting: Life sciences consulting firm focused on market access, commercial analytics, and launch strategy — a direct niche competitor for Petauri Advisors and MAx engagements.
• Eversana: Commercialization services provider offering market access, HEOR, patient services, and channel strategy; competes with Petauri Evidence, MAx, and Artia on pharma launch and lifecycle engagements.
• Avalere Health: Policy, market access, and evidence consultancy serving pharma and provider clients, including strong Medicaid and HTA practice — comparable to Petauri Advisors and Evidence.
• Real Chemistry: Healthcare marketing and communications platform with significant market access and medical communications capabilities, overlapping with Petauri Advance and MAx.
• Precision Medicine Group: Life sciences commercialization services organization sharing legacy lineage with Petauri (Precision Value & Health) and competing across market access, HEOR, and medical communications.

Broad incumbents

• Clarivate (Life Sciences & Healthcare): Large-scale analytics and consulting platform serving pharma clients across HEOR, real-world evidence, and market access — a broader incumbent spanning adjacent service categories to Petauri.
• IQVIA: World's largest life sciences commercial services and data platform; competes with Petauri on market access, HEOR, real-world evidence, and broader pharma commercialization mandates.

Emerging players

• OM1: Specialized real-world evidence and AI-enabled data analytics platform for life sciences with partial overlap to Petauri's Connected Insights and HEOR capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/petauri-health
• Xx.com/PetauriHealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles25 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Petauri Health